137 related articles for article (PubMed ID: 26075444)
1. Prognostic factors in patients with recurrent or metastatic retroperitoneal leiomyosarcoma.
Li Q; Zhuang R; Zhu J; Lu W; Hou Y; Liu J; Zhang Y; Wang Y; Liu T; Wang Z; Zhou Y
Future Oncol; 2015; 11(12):1759-66. PubMed ID: 26075444
[TBL] [Abstract][Full Text] [Related]
2. [Predictors of local recurrence and survival in primary retroperitoneal leiomyosarcoma].
Chen G; Yan Y; Xiao C; Sun P; Xue H; Li R
Zhonghua Wai Ke Za Zhi; 2014 Feb; 52(2):105-8. PubMed ID: 24809517
[TBL] [Abstract][Full Text] [Related]
3. Histologic type predicts survival in patients with retroperitoneal soft tissue sarcoma.
Tseng W; Martinez SR; Tamurian RM; Borys D; Canter RJ
J Surg Res; 2012 Jan; 172(1):123-30. PubMed ID: 20869082
[TBL] [Abstract][Full Text] [Related]
4. Oncology outcomes in Retroperitoneal sarcomas: Prognostic factors in a Retrospective Cohort study.
Garcia-Ortega DY; Villa-Zepeda O; Martinez-Said H; Cuellar-Hübbe M; Luna-Ortiz K
Int J Surg; 2016 Aug; 32():45-9. PubMed ID: 27268726
[TBL] [Abstract][Full Text] [Related]
5. Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma.
Nathenson MJ; Barysauskas CM; Nathenson RA; Regine WF; Hanna N; Sausville E
World J Surg Oncol; 2018 Oct; 16(1):203. PubMed ID: 30309356
[TBL] [Abstract][Full Text] [Related]
6. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP
J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors analysis of Ki-67, α-SMA expression in retroperitoneal leiomyosarcoma].
Ma C; Li PY; Zhang N; Sun CB; Hou L; Liu N
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):258-263. PubMed ID: 29730911
[No Abstract] [Full Text] [Related]
8. [Retroperitoneal sarcomas: diagnostic and therapy].
Gockel I; Oberholzer K; Gönner U; Mantai S; Junginger T
Zentralbl Chir; 2006 Jun; 131(3):223-9. PubMed ID: 16739063
[TBL] [Abstract][Full Text] [Related]
9. Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?
Worhunsky DJ; Gupta M; Gholami S; Tran TB; Ganjoo KN; van de Rijn M; Visser BC; Norton JA; Poultsides GA
J Surg Oncol; 2015 Jun; 111(7):808-12. PubMed ID: 25920434
[TBL] [Abstract][Full Text] [Related]
10. Retroperitoneal soft-tissue sarcomas: prognosis and treatment of primary and recurrent disease.
Bautista N; Su W; O'Connell TX
Am Surg; 2000 Sep; 66(9):832-6. PubMed ID: 10993610
[TBL] [Abstract][Full Text] [Related]
11. Leiomyosarcoma of the inferior vena cava: clinicopathologic study of 40 cases.
Laskin WB; Fanburg-Smith JC; Burke AP; Kraszewska E; Fetsch JF; Miettinen M
Am J Surg Pathol; 2010 Jun; 34(6):873-81. PubMed ID: 20463568
[TBL] [Abstract][Full Text] [Related]
12. CREPT expression correlates with poor prognosis in patients with retroperitoneal leiomyosarcoma.
She Y; Liang J; Chen L; Qiu Y; Liu N; Zhao X; Huang X; Wang Y; Ren F; Chang Z; Li P
Int J Clin Exp Pathol; 2014; 7(10):6596-605. PubMed ID: 25400738
[TBL] [Abstract][Full Text] [Related]
13. [Retroperitoneal leiomyosarcoma: report of 3 cases].
El Atat R; Sfaxi M; Gargouri M; Ben Moualli S; Ben Hassine L; Chebil M; Ayed M
Tunis Med; 2007 May; 85(5):441-4. PubMed ID: 17657937
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors predicting postoperative survival period in the treatment of primary retroperitoneal leiomyosarcoma].
Zhao XD; Li PY; Huang XH; Chen L; Li R; Liu N
Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):891-4. PubMed ID: 24433766
[TBL] [Abstract][Full Text] [Related]
15. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
16. Retroperitoneal leiomyosarcomas unassociated with the gastrointestinal tract: a clinicopathologic analysis of 17 cases.
Rajani B; Smith TA; Reith JD; Goldblum JR
Mod Pathol; 1999 Jan; 12(1):21-8. PubMed ID: 9950158
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.
Trovik LH; Ovrebo K; Almquist M; Haugland HK; Rissler P; Eide J; Engellau J; Monge OR; Nyhus AB; Elde IK; Jebsen NL
Acta Oncol; 2014 Sep; 53(9):1165-72. PubMed ID: 25000415
[TBL] [Abstract][Full Text] [Related]
18. Primary and locally recurrent retroperitoneal soft-tissue sarcoma: local control and survival.
Lehnert T; Cardona S; Hinz U; Willeke F; Mechtersheimer G; Treiber M; Herfarth C; Buechler MW; Schwarzbach MH
Eur J Surg Oncol; 2009 Sep; 35(9):986-93. PubMed ID: 19138832
[TBL] [Abstract][Full Text] [Related]
19. Fédération Nationale Des Centres de Lutte Contre Le Cancer (FNCLCC) Grading, Margin Status and Tumor Location Associate With Survival Outcomes in Malignant Peripheral Nerve Sheath Tumors.
Wakeman KM; Zhang QS; Bandhlish A; Cranmer LD; Ricciotti RW; Mantilla JG
Am J Clin Oncol; 2022 Jan; 45(1):28-35. PubMed ID: 34962906
[TBL] [Abstract][Full Text] [Related]
20. Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma.
Gronchi A; Collini P; Miceli R; Valeri B; Renne SL; Dagrada G; Fiore M; Sanfilippo R; Barisella M; Colombo C; Morosi C; Stacchiotti S; Casali PG; Dei Tos AP; Pilotti S
Am J Surg Pathol; 2015 Mar; 39(3):383-93. PubMed ID: 25581729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
